655 related articles for article (PubMed ID: 18923405)
21. Brain-Derived Neurotrophic Factor: A Novel Dynamically Regulated Therapeutic Modulator in Neurological Disorders.
Sharma V; Singh TG; Kaur A; Mannan A; Dhiman S
Neurochem Res; 2023 Feb; 48(2):317-339. PubMed ID: 36308619
[TBL] [Abstract][Full Text] [Related]
22. BDNF-induced local protein synthesis and synaptic plasticity.
Leal G; Comprido D; Duarte CB
Neuropharmacology; 2014 Jan; 76 Pt C():639-56. PubMed ID: 23602987
[TBL] [Abstract][Full Text] [Related]
23. Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach.
Calabrese V; Scapagnini G; Colombrita C; Ravagna A; Pennisi G; Giuffrida Stella AM; Galli F; Butterfield DA
Amino Acids; 2003 Dec; 25(3-4):437-44. PubMed ID: 14661103
[TBL] [Abstract][Full Text] [Related]
24. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
25. Brain-derived neurotrophic factor-induced gene expression reveals novel actions of VGF in hippocampal synaptic plasticity.
Alder J; Thakker-Varia S; Bangasser DA; Kuroiwa M; Plummer MR; Shors TJ; Black IB
J Neurosci; 2003 Nov; 23(34):10800-8. PubMed ID: 14645472
[TBL] [Abstract][Full Text] [Related]
26. Neuropathology markers and pathways associated with molecular targets for antipsychotic drugs in postmortem brain tissues: exploration of drug targets through the Stanley Neuropathology Integrative Database.
Kim S; Zavitsanou K; Gurguis G; Webster MJ
Eur Neuropsychopharmacol; 2012 Oct; 22(10):683-94. PubMed ID: 22356822
[TBL] [Abstract][Full Text] [Related]
27. Proteomics analysis provides insight into caloric restriction mediated oxidation and expression of brain proteins associated with age-related impaired cellular processes: Mitochondrial dysfunction, glutamate dysregulation and impaired protein synthesis.
Poon HF; Shepherd HM; Reed TT; Calabrese V; Stella AM; Pennisi G; Cai J; Pierce WM; Klein JB; Butterfield DA
Neurobiol Aging; 2006 Jul; 27(7):1020-34. PubMed ID: 15996793
[TBL] [Abstract][Full Text] [Related]
28. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
Devi L; Ohno M
Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
[TBL] [Abstract][Full Text] [Related]
29. Drug development in Parkinson's disease: from emerging molecules to innovative drug delivery systems.
Garbayo E; Ansorena E; Blanco-Prieto MJ
Maturitas; 2013 Nov; 76(3):272-8. PubMed ID: 23827471
[TBL] [Abstract][Full Text] [Related]
30. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
31. Repetitive transcranial magnetic stimulation (rTMS) influences spatial cognition and modulates hippocampal structural synaptic plasticity in aging mice.
Ma J; Zhang Z; Kang L; Geng D; Wang Y; Wang M; Cui H
Exp Gerontol; 2014 Oct; 58():256-68. PubMed ID: 25172625
[TBL] [Abstract][Full Text] [Related]
32. Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration.
Angelucci F; Mathé AA; Aloe L
J Neurosci Res; 2000 Jun; 60(6):783-94. PubMed ID: 10861791
[TBL] [Abstract][Full Text] [Related]
33. D2 receptor partial agonists: treatment of CNS disorders of dopamine function.
Kehne JH; Andree TH; Heinrich JN
Curr Top Med Chem; 2008; 8(12):1068-88. PubMed ID: 18691133
[TBL] [Abstract][Full Text] [Related]
34. SCM-198 Ameliorates Cognitive Deficits, Promotes Neuronal Survival and Enhances CREB/BDNF/TrkB Signaling without Affecting Aβ Burden in AβPP/PS1 Mice.
Hong ZY; Yu SS; Wang ZJ; Zhu YZ
Int J Mol Sci; 2015 Aug; 16(8):18544-63. PubMed ID: 26262618
[TBL] [Abstract][Full Text] [Related]
35. [Possible relation of BDNF and GDNF to neuropsychiatric disorders].
Hibi Y; Nitta A; Nabeshima T; Yamada K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Apr; 29(2):85-9. PubMed ID: 19562947
[TBL] [Abstract][Full Text] [Related]
36. Smilagenin attenuates beta amyloid (25-35)-induced degeneration of neuronal cells via stimulating the gene expression of brain-derived neurotrophic factor.
Zhang R; Wang Z; Howson PA; Xia Z; Zhou S; Wu E; Xia Z; Hu Y
Neuroscience; 2012 May; 210():275-85. PubMed ID: 22441042
[TBL] [Abstract][Full Text] [Related]
37. TrkB activation by 7, 8-dihydroxyflavone increases synapse AMPA subunits and ameliorates spatial memory deficits in a mouse model of Alzheimer's disease.
Gao L; Tian M; Zhao HY; Xu QQ; Huang YM; Si QC; Tian Q; Wu QM; Hu XM; Sun LB; McClintock SM; Zeng Y
J Neurochem; 2016 Feb; 136(3):620-36. PubMed ID: 26577931
[TBL] [Abstract][Full Text] [Related]
38. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
Quinones MP; Kaddurah-Daouk R
Neurobiol Dis; 2009 Aug; 35(2):165-76. PubMed ID: 19303440
[TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.
Wu ZL; Ciallella JR; Flood DG; O'Kane TM; Bozyczko-Coyne D; Savage MJ
Neurobiol Aging; 2006 Mar; 27(3):377-86. PubMed ID: 15927307
[TBL] [Abstract][Full Text] [Related]
40. Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease.
Tiernan CT; Ginsberg SD; He B; Ward SM; Guillozet-Bongaarts AL; Kanaan NM; Mufson EJ; Counts SE
Neurobiol Dis; 2018 Sep; 117():125-136. PubMed ID: 29859871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
